Abstract:Abstract Several X-linked neurodevelopmental disorders including Rett syndrome, induced by mutations in the MECP2 gene, and fragile X syndrome (FXS), caused by mutations in the FMR1 gene, share autism-related features. The mRNA coding for methyl CpG binding protein 2 (MeCP2) has previously been identified as a substrate for the mRNA-binding protein, fragile X mental retardation protein (FMRP), which is silenced in FXS. Here, we report a homeostatic relationship between these two key regulators of gene expression in mouse models of FXS (Fmr1 Knockout (KO)) and Rett syndrome (MeCP2 KO). We found that the level of MeCP2 protein in the cerebral cortex was elevated in Fmr1 KO mice, whereas MeCP2 KO mice displayed reduced levels of FMRP, implicating interplay between the activities of MeCP2 and FMRP. Indeed, knockdown of MeCP2 with short hairpin RNAs led to a reduction of FMRP in mouse Neuro2A and in human HEK-293 cells, suggesting a reciprocal coupling in the expression level of these two regulatory proteins. Intra-cerebroventricular injection of an adeno-associated viral vector coding for FMRP led to a concomitant reduction in MeCP2 expression in vivo and partially corrected locomotor hyperactivity. Additionally, the level of MeCP2 in the posterior cortex correlated with the severity of the hyperactive phenotype in Fmr1 KO mice. These results demonstrate that MeCP2 and FMRP operate within a previously undefined homeostatic relationship. Our findings also suggest that MeCP2 overexpression in Fmr1 KO mouse posterior cerebral cortex may contribute to the fragile X locomotor hyperactivity phenotype.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mutual regulatory relationship between two key proteins in Fragile X Syndrome (FXS) and Rett Syndrome - Fragile X Mental Retardation Protein (FMRP) and Methyl CpG Binding Protein 2 (MeCP2). Specifically, the researchers hope to experimentally verify whether the expression levels of FMRP and MeCP2 in the posterior cerebral cortex of mice are interdependent, and explore the impact of this interaction on symptoms of neurodevelopmental disorders (such as hyperactivity). ### Research Background - **Fragile X Syndrome (FXS)** is caused by mutations in the FMR1 gene, resulting in the absence or abnormal function of the FMRP protein, and exhibiting characteristics of autism spectrum disorders such as intellectual disability, social communication disorders, and repetitive stereotyped behaviors. - **Rett Syndrome** is caused by mutations in the MECP2 gene, leading to impaired function of the MeCP2 protein, and also showing autism - like symptoms such as intellectual and motor deficits. ### Main Findings 1. **Mutual Regulation of FMRP and MeCP2**: - In Fmr1 knockout (KO) mice, the MeCP2 protein level is elevated. - In MeCP2 knockout (KO) mice, the FMRP protein level is decreased. - This indicates that there is a mutually regulatory homeostatic relationship between FMRP and MeCP2. 2. **Intracellular Expression of FMRP and MeCP2**: - Through immunofluorescence staining and confocal microscopy, it was found that in neurons of wild - type (WT) mice, FMRP is mainly located in the cytoplasm, while MeCP2 is mainly located in the nucleus. - In Fmr1 KO mice, the MeCP2 protein level is significantly increased, and in MeCP2 KO mice, the FMRP protein level is significantly decreased. 3. **Molecular Mechanisms of FMRP and MeCP2**: - Through immunoprecipitation experiments, it was confirmed that FMRP can bind to the mRNA of MeCP2, which may be a mechanism by which FMRP regulates the expression of MeCP2. - Using adeno - associated virus (AAV) - mediated FMRP over - expression experiments, it was found that the re - introduction of FMRP can reduce the expression level of MeCP2 and partially correct the hyperactive phenotype in Fmr1 KO mice. 4. **Relationship between MeCP2 and Hyperactivity**: - Through open - field experiments, it was found that the degree of hyperactivity in Fmr1 KO mice is positively correlated with the expression level of MeCP2 in the posterior cerebral cortex. - This finding suggests that the over - expression of MeCP2 may be related to the hyperactive phenotype in FXS. ### Conclusion This study reveals a previously unreported homeostatic regulatory relationship between FMRP and MeCP2, which may play an important role in the pathological mechanisms of Fragile X Syndrome and Rett Syndrome. Further research may contribute to the development of new treatment strategies for these neurodevelopmental disorders.

Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex

Downregulation of CNPase in a MeCP2 Deficient Mouse Model of Rett Syndrome.

Spatiotemporal Expression Of Psd-95 In Fmr1 Knockout Mice Brain

Fragile X Mental Retardation Protein is Required for Chemically‐induced Long‐term Potentiation of the Hippocampus in Adult Mice

Fragile X Mental Retardation Protein Modulates the Stability of Its M6a-Marked Messenger RNA Targets.

Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation Via Distinct Mechanisms

Modeling Fragile X Syndrome: Characterizing Fmr1 Gene Knockout Mice across Genotype, Behavior, and Morphology

Identification of a molecular locus for normalizing dysregulated GABA release from interneurons in the Fragile X brain

Cell- and Pathway-Specific Disruptions in the Accumbens of Fragile X Mouse

Manipulations of MeCP2 in Glutamatergic Neurons Highlight Their Contributions to Rett and Other Neurological Disorders.

Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis

Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay

Regulation of mRNA splicing by MeCP2 via epigenetic modifications in the brain

Fragile X Mental Retardation Protein Regulates Proliferation and Differentiation of Adult Neural Stem/Progenitor Cells

Elevated levels of FMRP-target MAP1B impair human and mouse neuronal development and mouse social behaviors via autophagy pathway

A Partial Loss of Function Allele of Methyl-Cpg-binding Protein 2 Predicts a Human Neurodevelopmental Syndrome.

Quantitative phosphoproteomics of murine Fmr1-KO cell lines provides new insights into FMRP-dependent signal transduction mechanisms

Variation of FMRP Expression in Peripheral Blood Mononuclear Cells from Individuals with Fragile X Syndrome

Disruption of the KH1 domain of Fmr1 leads to transcriptional alterations and attentional deficits in rats

Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome

Fragile X mental retardation protein (FMRP) interacting proteins exhibit different expression patterns during development